Gainesville, FL, United States of America

Colleen G LePrell

This inventor holds 5 USPTO granted patents. Top assignee: University of Michigan. Active years: 2011-2017.


% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 35(Granted Patents)


Location History:

  • Ypsilanti, MI (US) (2011 - 2012)
  • Gainesville, FL (US) (2015 - 2017)

Company Filing History:


Years Active: 2011-2017

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Colleen G LePrell: Innovator in Hearing Loss Treatment

Introduction

Colleen G LePrell is a prominent inventor based in Gainesville, FL (US). She has made significant contributions to the field of hearing loss treatment, holding a total of 5 patents. Her innovative approaches aim to improve the quality of life for individuals suffering from auditory impairments.

Latest Patents

Among her latest patents is a method for treating hearing loss. This method involves administering a composition that consists essentially of a biologically effective amount of vitamin A, vitamin E, vitamin C, a vasodilator comprising magnesium, and, optionally, a withanolide and/or resveratrol. This groundbreaking approach highlights her commitment to advancing medical treatments for hearing loss.

Career Highlights

Colleen G LePrell is affiliated with the University of Michigan, where she continues her research and development in the field of audiology. Her work has garnered attention for its potential to revolutionize how hearing loss is treated, making her a key figure in this area of study.

Collaborations

She has collaborated with notable colleagues such as Josef M Miller and Diane Prieskorn, further enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Colleen G LePrell's contributions to the field of hearing loss treatment exemplify her dedication to innovation and improving patient outcomes. Her work continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…